Suppression of Chronic Inflammation With Engineered Nanomaterials Delivering Nuclear Factor Jb Transcription Factor Decoy Oligodeoxynucleotides Publisher Pubmed



Farahmand L¹ ; Darvishi B¹ ; Majidzadeha K^{2, 3} Show Affiliations
Source: Drug Delivery Published:2017

Abstract

As a prototypical pro-inflammatory transcription factor, constitutive activation of NF-jB signaling pathway has been reported in several chronic inflammatory disorders including inflammatory bowel disease, cystic fibrosis, rheumatoid arthritis and cancer. Application of decoy oligodeoxynucleotides (ODNs) against NF-jB, as an effective molecular therapy approach, has brought about several promising outcomes in treatment of chronic inflammatory disorders. However, systematic administration of these genetic constructs is mostly hampered due to their instability, rapid degradation by nucleases and poor cellular uptake. Both chemical modification and application of delivery systems have shown to effectively overcome some of these limitations. Among different administered delivery systems, nanomaterials have gained much attention for delivering NF-jB decoy ODNs owing to their high loading capacity, targeted delivery and ease of synthesis. In this review, we highlight some of the most recently developed nanomaterial-based delivery systems for overcoming limitations associated with clinical application of these genetic constructs. © 2017 The Author(s).